These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2087683)

  • 1. Experience of two teratology information services in Europe.
    Garbis JM; Robert E; Peters PW
    Teratology; 1990 Dec; 42(6):629-34. PubMed ID: 2087683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of Teratology Information Services (TIS).
    Hancock RL; Koren G; Einarson A; Ungar WJ
    Reprod Toxicol; 2007 Feb; 23(2):125-32. PubMed ID: 17184969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Providing information regarding exposures in pregnancy: a survey of North American Teratology Information Services.
    Hancock RL; Ungar WJ; Einarson A; Goodstadt M; Koren G
    Reprod Toxicol; 2008 Apr; 25(3):381-7. PubMed ID: 18423962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS.
    Schaefer C; Hannemann D; Meister R
    Reprod Toxicol; 2005; 20(3):331-43. PubMed ID: 15978773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug safety in pregnancy: utopia or achievable prospect? Risk information, risk research and advocacy in Teratology Information Services.
    Schaefer C
    Congenit Anom (Kyoto); 2011 Mar; 51(1):6-11. PubMed ID: 21158950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paternal exposure and counselling: experience of a Teratology Information Service.
    De Santis M; Cesari E; Cavaliere A; Ligato MS; Nobili E; Visconti D; Caruso A
    Reprod Toxicol; 2008 Sep; 26(1):42-6. PubMed ID: 18598753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection bias in Teratology Information Service pregnancy outcome studies.
    Johnson KA; Weber PA; Jones KL; Chambers CD
    Teratology; 2001 Aug; 64(2):79-82. PubMed ID: 11460258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of prenatal methimazole exposure.
    Di Gianantonio E; Schaefer C; Mastroiacovo PP; Cournot MP; Benedicenti F; Reuvers M; Occupati B; Robert E; Bellemin B; Addis A; Arnon J; Clementi M
    Teratology; 2001 Nov; 64(5):262-6. PubMed ID: 11745832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of drug-induced congenital defects.
    De Santis M; Straface G; Carducci B; Cavaliere AF; De Santis L; Lucchese A; Merola AM; Caruso A
    Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):10-9. PubMed ID: 15474237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations.
    Schaefer C; Ornoy A; Clementi M; Meister R; Weber-Schoendorfer C
    Reprod Toxicol; 2008 Sep; 26(1):36-41. PubMed ID: 18588969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge transfer and translation: examining how teratogen information is disseminated.
    Shahin I; Einarson A
    Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):956-61. PubMed ID: 21948595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmarketing surveillance for drug safety in pregnancy: the Organization of Teratology Information Services project.
    Felix RJ; Jones KL; Johnson KA; McCloskey CA; Chambers CD;
    Birth Defects Res A Clin Mol Teratol; 2004 Dec; 70(12):944-7. PubMed ID: 15570610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Information services on teratogens and agents toxic for the reproduction].
    Garbis-Berkvens JM; Peters PW
    Ned Tijdschr Geneeskd; 1991 Mar; 135(9):384-7. PubMed ID: 2014060
    [No Abstract]   [Full Text] [Related]  

  • 14. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.
    Garbis H; Elefant E; Diav-Citrin O; Mastroiacovo P; Schaefer C; Vial T; Clementi M; Valti E; McElhatton P; Smorlesi C; Rodriguez EP; Robert-Gnansia E; Merlob P; Peiker G; Pexieder T; Schueler L; Ritvanen A; Mathieu-Nolf M
    Reprod Toxicol; 2005; 19(4):453-8. PubMed ID: 15749258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing concerns of pregnant and lactating women after the 2005 hurricanes: the OTIS response.
    Quinn D; Lavigne SV; Chambers C; Wolfe L; Chipman H; Cragan JD; Rasmussen SA
    MCN Am J Matern Child Nurs; 2008; 33(4):235-41. PubMed ID: 18664905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment of drug use in pregnancy: prevention of birth defects.
    Peters PW
    Ann Ist Super Sanita; 1993; 29(1):131-7. PubMed ID: 8129259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Israel Teratogen Information Service: a report of the last ten years with 20,613 calls].
    Ornoy A; Shechtman S; Arnon J
    Harefuah; 1999 Jan; 136(1):1-9, 96. PubMed ID: 10914148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems of using data from Teratology Information Services (TIS) to identify putative teratogens.
    Martínez-Frías ML; Rodríguez-Pinilla E
    Teratology; 1999 Aug; 60(2):54-5. PubMed ID: 10440772
    [No Abstract]   [Full Text] [Related]  

  • 20. Fetal exposure to isotretinoin-an international problem.
    Garcia-Bournissen F; Tsur L; Goldstein LH; Staroselsky A; Avner M; Asrar F; Berkovitch M; Straface G; Koren G; De Santis M
    Reprod Toxicol; 2008 Jan; 25(1):124-8. PubMed ID: 18077132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.